king hepatitis C virus
Nature Immunology
2013년11월18일
The mechanism by which variations in the genetic sequence near the gene encoding human interferon lambda (IFNL) are associated with clearance of the hepatitis C virus (HCV) is revealed in a report published online this week in Nature Immunology.
Ram Savan and colleagues found that one particular genetic variant produces more stable IFN-lambda messenger RNA and this leads to increased production of this anti-viral factor. The authors also find HCV tries to ‘escape’ the immune response by aiding in IFN-lambda degradation. Again, the ‘protective’ IFN-lambda variant is more resistant to this degradation process.
The identification of this resistant IFN-lambda variant may explain why certain patients successfully clear HCV following drug treatment whereas a significant minority remain chronically infected.
doi: 10.1038/ni.2758
리서치 하이라이트
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature
-
6월10일
Animals: Genetic clues to how dogs became man’s best friendsScientific Reports
